SCHEMBL23975325

SCHEMBL23975325

c1ccc(-c2nc(-c3ccc(-c4cccc5c4oc4c(-c6ccccc6-c6ccccc6)cccc45)cc3)nc(-c3cccc4c3oc3c(-c5ccccc5)cccc34)n2)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR55 Q9Y2T6 1/20 0.42
ALDH1A1 P00352 7/20 0.42
MAPT P10636 6/20 0.42
TSHR P16473 4/20 0.42
SMN1; SMN2 Q16637 4/20 0.42
KDM4E B2RXH2 4/20 0.42
HPGD P15428 3/20 0.42
ATM Q13315 2/20 0.42
L3MBTL1 Q9Y468 2/20 0.42
TP53 P04637 2/20 0.42
NFKB1 P19838 2/20 0.42
HSD17B10 Q99714 2/20 0.42
MAPK1 P28482 1/20 0.42
NFKB2 Q00653 1/20 0.42
RELA Q04206 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
PRKDC P78527 5/20 0.41
PIK3CB P42338 4/20 0.41
PIK3CG P48736 4/20 0.41
PIK3CD O00329 3/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21425280 0.98 GPR55 (0.44) GPR55ALDH1A1MAPTTSHRSMN1; SMN2
SCHEMBL22925271 0.95 ALDH1A1 (0.41) GPR55ALDH1A1MAPTTSHRSMN1; SMN2
SCHEMBL21425196 0.95 ALDH1A1 (0.43) GPR55ALDH1A1MAPTTSHRSMN1; SMN2
SCHEMBL16441438 0.95 ALDH1A1 (0.45) GPR55ALDH1A1MAPTTSHRSMN1; SMN2
SCHEMBL18216709 0.95 ALDH1A1 (0.45) GPR55ALDH1A1MAPTTSHRSMN1; SMN2
SCHEMBL24525894 0.94 ALDH1A1 (0.44) GPR55ALDH1A1MAPTTSHRSMN1; SMN2
SCHEMBL24216935 0.94 ALDH1A1 (0.44) GPR55ALDH1A1MAPTTSHRSMN1; SMN2
SCHEMBL21563813 0.94 ALDH1A1 (0.44) GPR55ALDH1A1MAPTTSHRSMN1; SMN2
SCHEMBL24217269 0.94 ALDH1A1 (0.44) GPR55ALDH1A1MAPTTSHRSMN1; SMN2
SCHEMBL17425653 0.94 ALDH1A1 (0.44) GPR55ALDH1A1MAPTTSHRSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210340103-A1 COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING SAME, AND ELECTRONIC APPARATUS THEREOF DUK SAN NEOLUX CO., LTD (KR) 2021-11-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210340103-A1 COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING SAME, AND ELECTRONIC APPARATUS THEREOF OR51E2, SLC39A11, WEE1 GPR55 4630/4885ALDH1A1 1489/4885MAPT 1837/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.